Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS: PVCT · Delayed Price · USD
0.196
0.00 (0.00%)
Apr 26, 2024, 9:47 AM EDT - Market open
PVCT Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 82 | 40 | 45 | 22 | 23 | 24 | 19 | 30 | 5 | 76 | 141 | Upgrade
|
| Market Cap Growth | - | -11.35% | 102.33% | -1.56% | -6.35% | 27.40% | -36.86% | 547.36% | -93.87% | -45.75% | -55.78% | Upgrade
|
| Enterprise Value | 84 | 42 | 48 | 24 | 47 | 44 | 33 | 40 | 4 | 62 | 123 | Upgrade
|
| PE Ratio | -15.18 | -12.98 | -12.78 | -3.45 | -2.71 | -2.91 | -2.34 | -2.24 | -0.19 | -3.11 | -13.73 | Upgrade
|
| PS Ratio | 147.74 | 72.21 | 45.93 | - | - | - | - | - | - | - | 33.66 | Upgrade
|
| PB Ratio | -5.30 | -5.30 | -7.29 | -5.36 | -0.76 | -1.01 | -1.10 | -3.02 | 1.35 | 4.68 | 5.58 | Upgrade
|
| P/FCF Ratio | -15.66 | -15.66 | -14.94 | -22.16 | -5.58 | -3.93 | -3.67 | -2.92 | -0.21 | -4.38 | -10.11 | Upgrade
|
| P/OCF Ratio | -15.66 | -15.66 | -14.94 | -22.16 | -5.58 | -3.93 | -3.67 | -2.93 | -0.21 | -4.38 | -10.16 | Upgrade
|
| EV/Sales Ratio | 151.32 | 75.80 | 48.12 | - | - | - | - | - | - | - | 29.50 | Upgrade
|
| EV/EBITDA Ratio | -14.38 | -14.49 | -14.08 | -5.09 | -9.92 | -8.09 | -4.51 | -2.99 | -0.15 | -2.58 | -8.59 | Upgrade
|
| EV/EBIT Ratio | -14.33 | -14.45 | -14.03 | -5.07 | -9.44 | -7.19 | -4.12 | -2.85 | -0.14 | -2.50 | -8.21 | Upgrade
|
| EV/FCF Ratio | -16.44 | -16.44 | -15.65 | -23.20 | -11.38 | -7.13 | -6.34 | -3.82 | -0.16 | -3.57 | -8.86 | Upgrade
|
| Debt / Equity Ratio | -0.40 | -0.40 | -0.35 | -0.42 | -0.79 | -0.85 | -0.80 | -0.94 | 0 | 0 | 0 | Upgrade
|
| Debt / EBITDA Ratio | -1.03 | -1.04 | -0.65 | -0.38 | -5.08 | -3.73 | -1.90 | -0.71 | - | - | - | Upgrade
|
| Debt / FCF Ratio | -1.18 | -1.18 | -0.72 | -1.72 | -5.82 | -3.29 | -2.68 | -0.91 | - | - | - | Upgrade
|
| Quick Ratio | 0.11 | 0.11 | 0.00 | 0.09 | 0.00 | 0.21 | 0.16 | 0.14 | 0.68 | 3.56 | 21.38 | Upgrade
|
| Current Ratio | 0.15 | 0.15 | 0.23 | 0.45 | 0.01 | 0.33 | 0.25 | 0.24 | 0.85 | 3.57 | 22.53 | Upgrade
|
| Asset Turnover | 0.34 | 0.38 | 0.49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.16 | Upgrade
|
| Interest Coverage | -10.31 | 13.53 | -20.94 | -4.86 | -2.84 | -4.33 | -8.26 | 67.37 | 289.22 | 162.82 | 5.29 | Upgrade
|
| Return on Equity (ROE) | 41.44% | 40.85% | 57.06% | 155.26% | 27.89% | 34.80% | 46.81% | 134.92% | -704.12% | -150.17% | -40.66% | Upgrade
|
| Return on Assets (ROA) | -217.21% | -214.09% | -174.46% | -185.04% | -1430.02% | -567.24% | -410.07% | -393.37% | -435.35% | -119.88% | -39.12% | Upgrade
|
| Return on Capital (ROIC) | 64.87% | 64.05% | 84.77% | 191.23% | 77.44% | 170.35% | 229.76% | 2437.89% | -706.56% | -151.09% | -50.15% | Upgrade
|
| Earnings Yield | -3.82% | -7.70% | -7.82% | -28.96% | -36.94% | -34.40% | -42.65% | -44.65% | -522.29% | -32.11% | -7.28% | Upgrade
|
| FCF Yield | -3.12% | -6.39% | -6.70% | -4.51% | -17.91% | -25.42% | -27.23% | -34.28% | -469.04% | -22.82% | -9.89% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.01% | -2.76% | -3.81% | -1.72% | -1.11% | -3.55% | -57.89% | -19.52% | -11.28% | -33.20% | Upgrade
|
| Total Shareholder Return | -0.01% | -0.01% | -2.76% | -3.81% | -1.72% | -1.11% | -3.55% | -57.89% | -19.52% | -11.28% | -33.20% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.